Recent lateral hire Jim Lundy was featured in legal and regional press, including in a Law360 article titled “Foley Adds 11-Year SEC Vet to Securities Team in Chicago,” and Politico’s “Illinois Playbook”.
Lundy noted that during his time working at the SEC’s Chicago office, he “became familiar with Foley and [its] attorneys when they were opposite me, and always had a great deal of respect for how they advocated for their clients.”
Coverage of Lundy’s move to the firm also appeared in Bloomberg Law, Attorney at Law Magazine, Law.com, Securities Docket, Legal Desire, and Chicago Daily Law Bulletin.
People
Related News
26 September 2024
In the News
Gregory Marino on NIL Litigation – 'Schools want to know where the line is, and now everything is in flux'
Foley & Lardner LLP special counsel Gregory Marino shared insight on the growing complexities of collegiate sports in the ABA Journal article, "Money and litigation tangle with recent rules for college athletes' NIL deals."
24 September 2024
In the News
Thomas Ferrante Assesses Recent HHS OIG Report on Remote Patient Monitoring
Foley & Lardner LLP partner Thomas Ferrante commented on the recently released report on remote patient monitoring from the U.S. Department of Health and Human Services Office of Inspector General (OIG) in the Fierce Healthcare article, “HHS watchdog flags potential remote monitoring fraud. Stakeholders say concerns about misuse are overblown.”
20 September 2024
In the News
David Rosen Featured for Insight on Looming FDA Final Rule for Cosmetic Manufacturing
Foley & Lardner LLP partner David Rosen is featured by CosmeticsDesign for his insights on the U.S. Food and Drug Administration's final rule establishing Good Manufacturing Practices for the cosmetics industry in the article, "Preparing for MoCRA’s 2025 cGMP deadline: What cosmetic manufacturers and suppliers need to know."